Details for Patent: 6,194,429
✉ Email this page to a colleague
Summary for Patent: 6,194,429
Title: | Alatrofloxacin parenteral compositions |
Abstract: | The present invention relates to alatrofloxacin mesylate substantially free of less polar impurities, to parenteral compositions of alatrofloxacin mesylate and to processes for purifying alatrofloxacin mesylate. |
Inventor(s): | Guinn; Robert Mark (Mystic, CT), Lambert; John Francis (North Stonington, CT), Guhan; Subramanian Sam (Niantic, CT), Walinsky; Stanley Walter (Mystic, CT) |
Assignee: | Pfizer Inc (New York, NY) |
Application Number: | 09/403,886 |
Patent Claim Types: see list of patent claims | Compound; Process; Use; Composition; |
Drugs Protected by US Patent 6,194,429
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,194,429
PCT Information | |||
PCT Filed | July 23, 1998 | PCT Application Number: | PCT/IB98/01122 |
PCT Publication Date: | February 11, 1999 | PCT Publication Number: | WO99/06430 |
International Family Members for US Patent 6,194,429
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 1031 | ⤷ Try a Trial | |||
Argentina | 015417 | ⤷ Try a Trial | |||
Austria | 259827 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |